COA on Every ProductUSP Certified MaterialsProudly Canadian ManufacturerAll Excipients: USP-Grade ◆ Low Endotoxin ◆ Low MetalRaw Materials Sourced from GMP-Manufacturing FacilitiesCOA on Every ProductUSP Certified MaterialsProudly Canadian ManufacturerAll Excipients: USP-Grade ◆ Low Endotoxin ◆ Low MetalRaw Materials Sourced from GMP-Manufacturing Facilities
Ipamorelin 10 mg
Ipamorelin 10 mg - Image 2

Ipamorelin 10 mg

Ipamorelin, a selective ghrelin-receptor agonist and growth-hormone secretagogue, 10 mg. For research purposes only.

🇨🇦 Canadian First Lyfe is the first manufacturer of dual chamber pens in Canada. Learn More →

Description

Ipamorelin is a selective ghrelin-receptor agonist and growth-hormone secretagogue, valued in research for its clean, targeted pattern of GH release.

Commonly explored in research for:

  • Selective GH release with minimal cortisol or prolactin impact
  • Ghrelin-receptor (GHS-R) signalling
  • Growth-hormone pulsatility and IGF-1 models
  • Appetite and metabolic research

Supplied as 10 mg lyophilized powder for reconstitution.

⚖️

Chemical Overview

Key identifiers & structural data

🔬 Structural Data

About Ipamorelin

Classificationstr
CAS Registry170851-70-4
Molecular Mass711.9
Residue Countstr
Chain SequenceAib-His-D-2-Nal
Molecular FormulaC38H49N9O5
🔗 View on PubChem
📑

Research Literature

Published studies & clinical data

Growth Hormone & IGF Research

Ipamorelin: A selective growth hormone secretagogue

2000 • PMID: 10876026

Raun K, Hansen BS, Johansen NL

Read Paper ↗
Journal of Endocrinology

Effects of ipamorelin on growth hormone release

2001 • PMID: 11312142

Jaspers C, Raun K, Hansen BS

Read Paper ↗
Clinical Endocrinology

Ipamorelin: Clinical applications

2002 • PMID: 12030819

Johansen NL, Hansen BS, Raun K

Read Paper ↗

Related products